Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives $33.86 Consensus Target Price from Analysts
Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) have been assigned a consensus rating of “Buy” from the six brokerages that are currently covering the firm, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 1-year price objective among analysts that have issued ratings on the […]